EMPA-REG OUTCOME® Improvements in CV Outcomes and Renal Endpoints

14, May, 2020

Prof. Wanner discusses the results of EMPA-REG OUTCOME®, including the significant improvements in CV outcomes and renal endpoints seen with use of empagliflozin on top of standard of care.